Dr. Ronnie Claiborne, MD

Dr. Claiborne practices at Central Valley Medical Group in Taft, California.

Dr. Claiborne's NPI, 1578503256, was assigned on June 8, 2006. Dr. Claiborne graduated from The University of New Mexico School of Medicine in 1987. Dr. Claiborne holds California license G66649.

Dr. Claiborne's primary practice is Central Valley Medical Group, at 333 S 10th St, Taft, CA 93268 in Kern County. The practice phone is (661) 323-2295.

Dr. Claiborne's primary practice is Central Valley Medical Group in Taft, California. Dr. Claiborne is also affiliated with Adventist Health Bakersfield. The medical group on file is Central Valley Medical Group. Dmand AI also links Dr. Claiborne to 3 more home health agencies, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Claiborne practices, 6 sites in all. Vendor and product names are available with a free account.

General practice is Dr. Claiborne's primary specialty in the NPI Registry, under taxonomy code 208D00000X. Dr. Claiborne is licensed in California.

Dmand AI lists acid reflux, acne, acute gastroduodenitis, acute skin infection, adjustment disease, alcohol use disorders, alzheimer's disease and aneurysm among the conditions Dr. Claiborne treats.

CMS data shows 2,264 Medicare services from Dr. Claiborne across 22 procedure codes in 2024, for 323 Medicare patients. Medicare paid $149,300 for them. Every service was in an office.

CMS counts 323 Medicare patients who saw Dr. Claiborne in 2024. The largest group is 65 to 74, with 154 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 61% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Claiborne's median patient age at 58, with 57% women.

In 2024, Dr. Claiborne wrote 4,587 Medicare Part D claims for 320 patients. 86% of them were for generic drugs. CMS names the drug for 3,971 of them, across 106 drugs with 11 or more claims each, at $345,990 in total drug cost. In 2023, CMS named 5,052 claims across 117 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 35 out of 100 for Dr. Claiborne for performance year 2024, reported individually. Dr. Claiborne accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Claiborne as offering telehealth. CMS counts 16 procedures of removal of skin lesions by Dr. Claiborne, more than 63% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 1,110 general payments to Dr. Claiborne from 71 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. AstraZeneca Pharmaceuticals LP paid the most, $2,467.

Dr. Claiborne graduated from The University of New Mexico School of Medicine in 1987.

Dr. Claiborne is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.